Mereo BioPharma Group plc (MREO)

Mereo BioPharma Group Statistics

Total Valuation

MREO has a market cap or net worth of $281.60 million. The enterprise value is $226.08 million.

Market Cap	281.60M
Enterprise Value	226.08M

Important Dates

The last earnings date was Tuesday, August 12, 2025, before market open.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

MREO has 159.10 million shares outstanding. The number of shares has increased by 11.99% in one year.

Current Share Class	n/a
Shares Outstanding	159.10M
Shares Change (YoY)	+11.99%
Shares Change (QoQ)	+1.93%
Owned by Insiders (%)	5.00%
Owned by Institutions (%)	41.13%
Float	100.47M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	563.20
Forward PS	n/a
PB Ratio	5.19
P/TBV Ratio	5.24
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	452.15
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.13, with a Debt / Equity ratio of 0.01.

Current Ratio	8.13
Quick Ratio	7.92
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-47.82

Financial Efficiency

Return on equity (ROE) is -74.61% and return on invested capital (ROIC) is -39.95%.

Return on Equity (ROE)	-74.61%
Return on Assets (ROA)	-35.13%
Return on Invested Capital (ROIC)	-39.95%
Return on Capital Employed (ROCE)	-81.01%
Revenue Per Employee	$13,889
Profits Per Employee	-$1.38M
Employee Count	36
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -62.47% in the last 52 weeks. The beta is 0.42, so MREO's price volatility has been lower than the market average.

Beta (5Y)	0.42
52-Week Price Change	-62.47%
50-Day Moving Average	1.96
200-Day Moving Average	2.62
Relative Strength Index (RSI)	49.88
Average Volume (20 Days)	1,270,783

Short Selling Information

Short Interest	10.49M
Short Previous Month	10.55M
Short % of Shares Out	9.28%
Short % of Float	n/a
Short Ratio (days to cover)	5.50

Income Statement

In the last 12 months, MREO had revenue of $500,000 and -$49.55 million in losses. Loss per share was -$0.32.

Revenue	500,000
Gross Profit	368,000
Operating Income	-44.62M
Pretax Income	n/a
Net Income	-49.55M
EBITDA	-44.01M
EBIT	-44.62M
Loss Per Share	-$0.32

Balance Sheet

The company has $56.13 million in cash and $601,000 in debt, giving a net cash position of $55.52 million or $0.35 per share.

Cash & Cash Equivalents	56.13M
Total Debt	601,000
Net Cash	55.52M
Net Cash Per Share	$0.35
Equity (Book Value)	54.18M
Book Value Per Share	0.34
Working Capital	53.86M

Cash Flow

In the last 12 months, operating cash flow was -$32.92 million and capital expenditures -$20,000, giving a free cash flow of -$32.94 million.

Operating Cash Flow	-32.92M
Capital Expenditures	-20,000
Free Cash Flow	-32.94M
FCF Per Share	-$0.21

Margins

Gross Margin	73.60%
Operating Margin	-8,923.40%
Pretax Margin	-9,909.60%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MREO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.99%
Shareholder Yield	-11.99%
Earnings Yield	-17.60%
FCF Yield	-11.70%

Analyst Forecast

The average price target for MREO is $7.40, which is 318.08% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.40
Price Target Difference	318.08%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MREO has an Altman Z-Score of 24.56 and a Piotroski F-Score of 2.

Altman Z-Score	24.56
Piotroski F-Score	2